Growth Metrics

Novartis Ag (NVS) Current Assets (2016 - 2025)

Novartis Ag's Current Assets history spans 12 years, with the latest figure at $30.5 billion for Q4 2025.

  • On a quarterly basis, Current Assets rose 2.55% to $30.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $30.5 billion, a 2.55% increase, with the full-year FY2025 number at $30.5 billion, up 2.55% from a year prior.
  • Current Assets hit $30.5 billion in Q4 2025 for Novartis Ag, up from $25.9 billion in the prior quarter.
  • Over the last five years, Current Assets for NVS hit a ceiling of $45.7 billion in Q4 2021 and a floor of $25.7 billion in Q2 2024.
  • Historically, Current Assets has averaged $32.8 billion across 5 years, with a median of $30.9 billion in 2021.
  • Biggest five-year swings in Current Assets: skyrocketed 54.07% in 2021 and later dropped 23.29% in 2024.
  • Tracing NVS's Current Assets over 5 years: stood at $45.7 billion in 2021, then fell by 19.27% to $36.9 billion in 2022, then fell by 17.42% to $30.5 billion in 2023, then dropped by 2.55% to $29.7 billion in 2024, then increased by 2.55% to $30.5 billion in 2025.
  • Business Quant data shows Current Assets for NVS at $30.5 billion in Q4 2025, $25.9 billion in Q2 2025, and $29.7 billion in Q4 2024.